Clinical trial
Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR)
NCT00211120 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Terminated
Key facts
| NCT number | NCT00211120 |
|---|---|
| Title | Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR) |
| Official title | Correction of Hemoglobin and Outcomes In Renal Insufficiency |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Collaborators | Ortho Biotech Clinical Affairs, L.L.C. Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Epoetin Alfa |
| Enrollment | 1,432 |
| Start date | Mar 1, 2002 |
| Completion | Aug 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | May 18, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: